LFCR Q4 2018 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$141M+10.7% YoY

Gross Profit

$25M17.6% margin

Operating Income

$8M5.7% margin

Net Income

$6M4.3% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$405M

Total Liabilities

$152M

Stockholders' Equity

$253M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$127M	+10.7%
Gross Profit	$25M	$20M	+26.2%
Operating Income	$8M	$2M	+230.6%
Net Income	$6M	$2M	+149.1%